Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe.
A total of 93 Bos taurus cattle was used in pen trials to compare vaccine stocks of Anaplasma centrale from South Africa and Australia (which stock came from South Africa in 1934) in protecting against three virulent field isolates from clinical Anaplasma marginale infections. In addition, field observations were made on the use of a vaccine, prepared from the Australian stock, in over 9553 cattle of mixed age and breeds on 16 co-operator farms and at one communal dip. The results of the pen trials indicated that the two vaccine stocks were comparable and that neither provided adequate protection against two of the three isolates of A. marginale. The field observations indicated that the vaccine was highly infective and produced mild reactions in most recipient cattle, and that users were generally satisfied with the vaccine. These somewhat conflicting results are discussed in the context of observations in Australia and future vaccination against anaplasmosis in Zimbabwe.
Turton
J A
JA
Central Veterinary Laboratory, Department of Veterinary Services, Causeway, Harare, Zimbabwe.
Katsande
T C
TC
Matingo
M B
MB
Jorgensen
W K
WK
Ushewokunze-Obatolu
U
U
Dalgliesh
R J
RJ
D000704:Analysis of Variance; D000709:Anaplasma / Q000276:immunology* / Q000302:isolation & purification; D000712:Anaplasmosis / Q000097:blood / Q000517:prevention & control*; D000818:Animals; D001428:Bacterial Vaccines; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000517:prevention & control*; D014611:Vaccination / Q000662:veterinary*; D015030:Zimbabwe
D001428:Bacterial Vaccines